NFE2L2 and glioblastoma: Interestingly, our data reveal that combined treatment with CXB and TMZ significantly increased ROS levels in GBM cells, leading to a reduction in p-Nrf2 expression and detoxification-related genes in both primary GBM cultures and cell lines, regardless of their MGMT status.